Article | October 14, 2021

eCOA Solutions In Oncology: How To Avoid Common Pitfalls And Ensure The Success Of Long-Term Studies?

Source: Kayentis
Girl patient oncology

Conducting oncology studies is becoming more and more difficult. The rising complexity of protocol design, the difficulty to identify meaningful endpoints, and the increasing volume of those endpoints combine to generate a significant level of complexity. To add to this, the competition between clinical trials at the level of the study sites and the multiplicity of tools and systems to run a given study are also factors that have a significant impact on the implementation and conduct of clinical studies at clinical cancer centers. A 2019 report showed that despite accounting for almost 30% of the R&D product pipeline in 2018, composite success rates for oncology studies are only 8%.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader